LI
MDGL icon

Leap Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Leap Investments’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		$272K Buy
+2,400
New +$236K 0.18% 226
2019
Q4 		– Sell
-11,400
Closed -$983K – 515
2019
Q3 		$983K Buy
11,400
+6,500
+133% +$610K 0.49% 50
2019
Q2 		$514K Buy
+4,900
New +$525K 0.69% 38

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Leap Investments's MDGL Position: Q2 2020 in Review

Leap Investments opened a new position in Madrigal Pharmaceuticals (MDGL) in Q2 2020: 2,400 shares worth $272K. The stake represents 0.18% of the portfolio and ranks #226 among its holdings. This is a return to the name: Leap Investments previously reported a position in MDGL as recently as Q3 2019.

Leap Investments first reported a position in MDGL in Q2 2019 and has held it in 3 quarters since. The position peaked at $983K in Q3 2019. 125 funds tracked by Wall St. Rank hold MDGL as of Q2 2020.

  • Leap Investments held 2,400 shares of Madrigal Pharmaceuticals worth $272K as of Q2 2020.
  • Madrigal Pharmaceuticals was a new Leap Investments position in Q2 2020.
  • Madrigal Pharmaceuticals made up 0.18% of Leap Investments's portfolio in Q2 2020, its #226 holding.
  • Leap Investments first reported a position in Madrigal Pharmaceuticals in Q2 2019 and has held it in 3 quarters since.
  • Leap Investments's Madrigal Pharmaceuticals position peaked at $983K in Q3 2019.
  • 125 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2020.

Based on Leap Investments's 13F filing for Q2 2020, filed 3 Aug 2020.